This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Annals

Resveratrol and Health: 3rd International Conference

Edited by Edited by Ole Vang (Roskilde University, Roskilde, Denmark) and John M. Pezzuto (University of Hawaii at Hilo, Hilo, Hawaii)
Explore the Table of Contents
Resveratrol and Health: 3rd International Conference

Published: August 2015

Volume 1348

Recent findings on the biological effects and therapeutic potential of resveratrol and its derivatives.
Learn More

Resveratrol, a naturally occurring polyphenol found in red grapes (wine), peanuts, and berries, has been linked to health and disease prevention because of its demonstrated cardioprotective, antioxidative, anti-inflammatory, and anticancer effects. However, because of limitations including rapid metabolism and low bioavailability, only limited clinical trials of resveratrol have been possible. To share recent findings on the biological effects of resveratrol and its derivatives and discuss new directions for resveratrol research, the conference “Resveratrol2014, the Third International Conference on Resveratrol and Health” was convened from November 30 to December 3, 2014 in Hawaii. This Annals volume presents a collection of papers stemming from this conference and covers a range of topics, including the mechanisms of action and therapeutic potential of resveratrol in pancreatic cancer, prostate cancer, heart failure, dystrophic cardiomyopathy, ischemic heart disease, atrial fibrillation, osteoporosis, and polycystic ovary syndrome. Also discussed are the challenges in analyzing the biological effects of resveratrol; new ways of regulation by resveratrol involving miRNAs, with emphasis on inflammation; dendrimer nanotechnology for enhanced formulation and controlled delivery of resveratrol; resveratrol metabolite profiling in clinical nutrition research; and lastly, resveratrol and health from a consumer perspective.